2024-11-08 - Analysis Report
##  ABBV Stock Analysis Report

**Company Overview:** AbbVie Inc. is a global biopharmaceutical company that develops, manufactures, and markets pharmaceutical products.

**Performance Analysis:**

**1. Rate of Return vs S&P 500 (VOO):**

* **Cumulative Return:** ABBV: 160.77%, VOO: 139.88%
* **Divergence:** 20.89% (62.0% relative to historical range)

ABBV has outperformed the S&P 500 by 20.89%. This indicates a strong historical performance, but it's important to note that past performance is not indicative of future results. 

**Alpha and Beta Analysis:**

The provided data shows that ABBV has consistently outperformed the market (Alpha > 0) in most periods.  The Beta is consistently lower than 1, indicating lower volatility compared to the market.

**2. Recent Price Movement:**

* **Closing Price:** $201.2 (Last Market: $200.47)
* **5-Day Moving Average:** $202.15
* **20-Day Moving Average:** $193.8
* **60-Day Moving Average:** $194.61

The stock price is above both the 5-day and 20-day moving averages, suggesting potential for continued upward momentum. However, it is still below the 60-day moving average, indicating a short-term bullish trend but with potential for correction.

**3. Technical Indicators:**

* **RSI:** 70.47: The stock is currently in overbought territory, suggesting potential for a short-term correction.
* **PPO:** 0.71:  A positive PPO reading indicates bullish momentum, but it's also approaching overbought levels.
* **Delta_Previous_Relative_Divergence:** 2.35 (+):  This shows a short-term upward trend in relative strength.
* **Expected Return:** 2.97%: This suggests a potential for long-term outperformance compared to the S&P 500, assuming the current trend continues.

**4. Recent Earnings & Outlook:**

| Date        | EPS      | Expected EPS |
|--------------|----------|--------------|
| 2024-10-30 | 3        | 2.92         |
| 2024-07-25 | 2.65      | 2.57         |
| 2024-04-26 | 2.31      | 2.26         |
| 2024-02-02 | 2.79      | 2.76         |
| 2023-10-27 | 2.95      | 2.86         |

The recent earnings results have consistently exceeded expectations. This indicates strong profitability and potential for continued growth.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter     | Revenue    | Profit Margin |
|-------------|------------|---------------|
| 2024-09-30 | $14.46B    | 70.87%        |
| 2024-06-30 | $14.46B    | 70.94%        |
| 2024-03-31 | $12.31B    | 66.74%        |
| 2023-12-31 | $14.30B    | 60.11%        |
| 2023-09-30 | $13.93B    | 53.44%        |

The company has demonstrated strong revenue growth and consistent high profitability. The profit margins have been decreasing, but they are still significant. 

**Capital and Profitability:**

| Quarter     | Equity     | ROE        |
|-------------|------------|-------------|
| 2024-09-30 | $6.03B    | 25.88%      |
| 2024-06-30 | $6.78B    | 20.21%      |
| 2024-03-31 | $8.01B    | 17.10%      |
| 2023-12-31 | $10.36B   | 7.93%       |
| 2023-09-30 | $12.09B   | 14.70%      |

The company has strong capital and profitability, with a high ROE indicating efficient use of equity to generate profits. However, the ROE has been declining in recent quarters, which could be a factor to consider.

**6. News & Recent Issues:**

[Insert recent news and analysis from sources like Shacknews, FINBOLD, etc. Include recent market outlook, analyst opinions, and performance highlights.]

**7. Summary:**

ABBV has demonstrated a strong track record of outperforming the market, with consistent profitability and strong financial performance. However, technical indicators suggest a potential for a short-term correction due to overbought conditions. While recent earnings have been positive, some metrics like ROE are showing signs of decline. Further analysis of recent news and analyst opinions is crucial before making any investment decisions.

**Overall, ABBV appears to be a promising investment with potential for long-term growth. However, investors should be cautious about potential short-term volatility and monitor the company's performance closely.**
